Chang Gong Liu

Working at the forefront of molecular and cellular biology, Dr. Chang-Gong Liu has made numerous contributions to the field. He has led research efforts at public and private institutions, earned several patents, and published a large number of scholarly papers.

Currently employed at one of the world’s top research facilities, the MD Anderson Cancer Center of the University of Texas, Dr. Chang-Gong Liu accesses the latest in technology, information, and research to guide the organization towards its goal of finding treatments and a cure for cancer. Educated abroad, Dr. Chang-Gong Liu earned a Bachelor of Science in Embryological Biology and a Master of Science in Developmental Biology from Shandong University in Jinan, China. One of the top research schools in the nation, the University is especially well known for its contributions to the field of medicine. While in attendance, Dr. Chang-Gong Liu combined his scholastic responsibilities with work as a research associate and lecturer in the Department of Biology.

He later pursued his Ph.D. at the University of Vienna in Austria, focusing his research skills on biochemistry as well as molecular and cellular biology. Following completion of his education, Dr. Chang-Gong Liu accepted postdoctoral positions in the United States, initially with New Jersey’s Robert Wood Johnson Medical School, followed by a shorter period with Rutgers, The State University of New Jersey. Entering the private workforce with a position at Motorola Life Sciences, Dr. Liu held senior scientist and project leader roles for a total of three years. During this time, he created the first non-coding RNA/microRNA biochip.

In 2002, Dr. Chang-Gong Liu took his research talents to a series of academic institutions, including Thomas Jefferson University, The Ohio State University, and his current location, the University of Texas.